Hormone replacement therapy and diabetes mellitus

Clinical Endocrinology

Volumn 44, Issue 6, 1996, Pages 615-620

  Dunne, Fidelma P ^a,b   Harris, P ^a   Keane, L ^a   Jenkins, David ^a   Wright, Alexander D ^a  

^a GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0029943239     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.7540770.x     Document Type: Review

References (48)

1. Adami, S., Rossini, M., Zamberlan, N., Bertolda, F., Dorizzi, R. & La Cascio, V. (1993) Long-term effects of transdermal and oral oestrogens on serum lipids and lipoproteins in postmenopausal women. Maturitas, 17, 191-196.
2. Barrett-Connor, E. (1992) Hormone replacement and cancer. British Medical Bulletin. 48, 345-355.
3. Boston Collaborative Drug Surveillance Program (1974) Surgically confirmed gallbladder disease, venous thromboembolism and breast tumours in relation to postmenopausal oestrogen therapy. New England Journal of Medicine, 290, 15-19.
4. Bouillon. R. (1992) Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-1 production. Verhandelingen-Koninklijke Academie Voor Geneeskunde van Belgie, 54, 365-391.
5. Colditz, G.A., Hankinson, S.E., Hunter, D.J., Willett, W.C., Manson, J.E., Stampfer, M.J., Hennekens, C., Rosner, B. & Speizer, F.E. (1995) The use of oestrogens and progestins and the risk of breast cancer in postmenopausal women. New England Journal of Medicine, 332, 1589-1593.
6. Crook, D., Cust, M., Gangar, K., Worthington, M., Hillard, T., Stevenson, J., Whitehead, M. & Wynn, V. (1992) Comparison of transdermal and oral oestrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. American Journal of Obstetrics and Gynaecology, 166, 950-955.
7. Devor, M., Barrett-Connor, E., Renvall, M., Feigal, D. & Ramsdell. J. (1992) Oestrogen replacement therapy and the risk of venous thrombosis. American Journal of Medicine, 92, 275-282.
8. Drife, J.O. (1989) Hormone replacement therapy. Prescribers Journal, 29, 131-138.
9. Dupont, W.D. & Page, D.L. (1991) Menopausal oestrogen replacement therapy and breast cancer. Annals of Internal Medicine, 151, 67-72.
10. Erenus, M., Kutlay, K., Kutlay, L. & Pekin, S. (1994) Comparison of the impact of oral versus transdermal oestrogen on serum lipoproteins. Fertility and Sterility, 61, 300-302.
11. Folsom, A.R., Minic, P.J., Sellers, T.A., Hong, C.P., Zheng, W. & Potter, J.D. (1995) Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. American Journal of Public Health, 85, 1128-1131.
12. Gallacher, S.J., Fenner, J.A., Fisher, B.M., Quin, J.D., Fraser, W.D., Logue, F.C., Cowan, R.A., Boyle, I.T. & MacCuish, A.C. (1993) An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus. Diabetic Medicine, 10, 129-133.
13. Goddard, M. (1990) The cost effectiveness of hormone replacement therapy: A review. Discussion paper 73. Centre for Health Economics, University of York.
14. Godsland, I.F., Gansar, K., Walton, C., Cast, M.P., Whitehead, M.I., Wynn, V. & Stevenson, J.C. (1993) Insulin resistance, secretion and elimination in post-menopausal women receiving oral or transdermal hormone replacement therapy. Metabolism, 42, 846-853.
15. Jensen, G.F., Christiansen, C., Boesen, J., Hegedus, V. & Transbol, I. (1982) Epidemiology of post-menopausal spinal and long bone fractures: a unifying approach to post-menopausal osteoporosis. Journal of Orthopedic Research, 166, 75-81.
16. Jespersen, C.M., Arnung, K., Hagen, C., Kilden, T., Nielsen, F., Nielsen, M.D. & Giese, J. (1983) Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women. Journal of Hypertension, 1, 361-364.
17. Khaw, K.-T. & Peart, W.S. (1982) Blood pressure and contraceptive use. British Medical Journal, 285, 403-407.
18. La Vecchia C., Negri, E., Franceschi, S., D'Avanzo, B. & Boyle, P. (1994) A case-control study of diabetes mellitus and cancer risk. British Journal of Cancer, 70, 950-953.
19. Lemay, A., Dodin, S., Cedrin, I. & Lemay, L. (1995) Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate. Clinical Endocrinology, 42, 341-351.
20. Lip, G.Y.H., Beevers, M., Churchill, D. & Beevers, D.G. (1994) Hormone replacement therapy and blood pressure in hypertensive women. Journal of Human Hypertension, 8, 491-494.
21. Maatela, J., Aromaa, A., Salmi, T., Pohja, M., Vuento, M. & Gronroos, M. (1994) The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record-linkage study in Finland. Annals Chirurgiae et Gynaecologiae, 208(Suppl.), 20-24.
22. Mann, R.D., Lis, Y., Chukwujindu, J. & Chanter, D.O. (1994) A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarcation in women. Journal of Clinical Epidemiology, 47, 307-312.
23. Manson, J.E. (1992) A prospective study of postpartum oestrogen therapy and subsequent incidence of non insulin dependent diabetes mellitus. Annals of Epidemiology, 2, 665-673.
24. Melton, L.J., Wahner, H.W., Richelson, L.S., O'Fallan, W.M. & Riggs, B.I. (1986) Osteoporosis and the risk of hip fracture. American Journal of Epidemiology, 124, 254-261.
25. Nabulsi, A.A., Folsom, A.R. & White, A. (1993) Association of hormone replacement therapy with various cardiovascular risk factors in post-menopausal women. New England Journal of Medicine, 328, 1069-1075.
26. Nachtigall, L.E., Nachtigall, R.H., Nachtigall, R.D. & Beckman, E.M. (1979) Oestrogen replacement therapy. II A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstetrics and Gynecology, 54, 74-79.
27. PEPI Trial Writing Group (1995) Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in post-menopausal women. Journal of the American Medical Association, 273, 199-208.
28. Perry, I., Beevers, M., Beevers, D.G. & Leusley, D. (1988) Oestrogens and cardiovascular disease. British Medical Journal. 297, 1127.
29. Persson, I., Adami, H.O. & Bergkvist, L. (1988) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. British Medical Journal, 298, 147-151.
30. Pfeffer, R.I., Kurosaki, T.T. & Charlton, S.K. (1979) Oestrogen use and blood pressure in later life. American Journal of Epidemiology, 110, 469-478.
31. Realini, J.P. & Goldzieher, J.W. (1985) Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. American Journal of Obstetrics and Gynecology, 152, 729-798.
32. Saneshige, S. (1992) Spinal bone mineral density in the female diabetic population. Japanese Journal of Geriatrics, 29, 864-873.
33. Selby, P.L. (1988) Osteopenia and diabetes. Diabetic Medicine, 5, 423-428.
34. Spector, T.D. (1989) Use of oestrogen replacement therapy in high risk groups in the United Kingdom. British Medical Journal, 299, 1434-1435.
35. Speroff, L. (1992) The risk of breast cancer associated with oral contraception and hormone replacement therapy. Womens Health Issues, 2, 63-72.
36. Staessen, J., Bulpitt, C.J., Fagard, R., Lijnen, P. & Amery, A. (1989) The influence of menopause on blood pressure. Journal of Human Hypertension, 3, 427-433.
37. Stanford, J.L., Weiss, N.S., Voigt, L.F., Daling, J.R., Habel, L.A. & Rossing, M.A. (1995) Combined oestrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA, 274, 137-142.
38. Stevenson, J.C. (1987) Assessment of therapeutic options for prevention of bone loss. In Osteoporosis eds C. Christiansen. J.S. Johansen & B.J. Riis), pp. 489-493.
39. Stevenson, J.C., Crook, D., Godsland, I.F., Lees, B. & Whitehead, M.I. (1993) Oral versus transdermal hormone replacement therapy. International Journal of Fertility and Menopausal Studies, 38, 30-35.
40. Stevenson, J.C., Lees, B., Devenport, M., Cust, M.P. & Ganger, K.F. (1989) Determinents of bone density in normal women: risk factors for future osteoporosis? British Medical Journal, 298, 924-928.
41. Stevenson, J.C. & Whitehead, M.I. (1982) Post menopausal osteoporosis. British Medical Journal, 285, 585-588.
42. Sturdee, D.W. (1994) Hormone replacement therapy: the benefits and risks. Prescribes Journal, 34, 234-242.
43. Tikkanen, M.J., Kuusi, T., Nikkila, E.A. & Sipinen, S. (1986) Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. Maturitas, 8, 7-17.
44. Varizi, S.M., Evans, J.C. Larson, M.G. & Wilson, P.W.F. (1993) The impact of female hormone usage on the lipid profile. The Framingham Offspring Study. Archives of Internal Medicine, 153, 22006.
45. Wahl, P., Walden, C., Knopp, R., Hoover, J., Wallace, R., Heiss, G. & Rifkind, B. (1983) Effect of oestrogen/progestin potency on lipid/lipoprotein cholesterol. New England Journal of Mecicine, 308, 862-867.
46. Wakasugi, M., Wakao, R., Tawata, M., Gan N., Koizumi, K. & Onaya, T. (1993) Bone mineral density as measured by dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone, 14, 29-33.
47. Whiteroft, S.I.J. & Stevenson, J.C. (1992) Hormone replacement therapy: risks and benefits. Clinical Endocrinology, 36, 15-20.
48. Ziegler, R. (1992) Diabetes mellitus and bone metabolism. Hormone Metabolism and Research. 26(Suppl.), 90-94.